WTW announces appointment of Sean Plankey as Global Leader Cybersecurity Software
LONDON, April 08, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced […]
TSX News -
Wesdome Provides Kiena Exploration Update; Drilling Continues to Grow Kiena Deep and Intercept High Grades Near Mine Infrastructure
TORONTO, April 08, 2024 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO, OTCQX: WDOFF) (“Wesdome” or the “Company”) today […]
SIRONA BIOCHEM Corporate Update April 2024
VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or […]
Caledonia Mining Corporation Plc: Appointment of Chief Operating Officer
ST HELIER, Jersey, April 08, 2024 (GLOBE NEWSWIRE) — Caledonia Mining Corporation Plc (“Caledonia” or the “Company”) (NYSE AMERICAN: CMCL; AIM: […]
La Dette à Long Terme de CGG Revue à la Hausse par S&P
Paris, France – le 8 avril 2024 CGG annonce aujourd’hui que S&P Global Ratings (” S&P”) a relevé la note […]
CGG’s Long Term Debt Upgraded by S&P
PARIS, France – April 8, 2024 CGG today announced that S&P Global Ratings (“S&P”) has upgraded the Company’s issuer credit […]
Pharming announces completion of enrollment in pediatric clinical trial of leniolisib
This multinational Phase III study is evaluating leniolisib tablets in children aged 4 to 11 years with APDS, a rare […]
GLP Works with Foundry for AI by Rackspace (FAIR) Experts to Integrate Microsoft Azure OpenAI Service to Drive Innovative Asset Management Strategies
SINGAPORE, April 07, 2024 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), the leading end-to-end, hybrid multicloud solutions company, today announced […]
Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting
Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data show non-classical EGFR […]
Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting
SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the […]
